Molecular Data and Their Correlations With Clinical Outcomes in Gynecological Cancer Patients.
NCT05733793 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 300
Last updated 2023-02-23
Summary
Gynger is a no profit, observational study, composed of a retrospective cohort (A) and a prospective cohort (B). The primary aim of this trial is to describe gene profile of Italian gynecological cancers patients, through the centralization of NGS reports performed in clinical practice or collected in clinical trials, and to correlation them with clinical and pathologic features.
Conditions
- Gynecologic Cancer
Interventions
- OTHER
-
NGS tests
This study is an observational, the patients with have an available NGS report performed in context of clinical practice or collected in clinical trials. Patients enrolled in the current study will be managed as for clinical practice and no additional genetic tests or other procedure will be required.
Sponsors & Collaborators
-
National Cancer Institute, Naples
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2021-06-16
- Primary Completion
- 2025-06-16
- Completion
- 2025-06-16
Countries
- Italy
Study Locations
More Related Trials
-
Assessment of Screening Modalities for Gynecologic Cancers
NCT00879840 ·Status: COMPLETED
-
Molecular Biomarkers Predicting Early Development of Endometrial Carcinoma
NCT05273099 ·Status: UNKNOWN
-
Multidisciplinary Assesssment of Structured Report for Cervical Cancer Staging
NCT06260358 ·Status: RECRUITING
-
Evaluation of Salivary RNA in Subjects Scheduled for Surgery for a Gynecologic Pathology
NCT06392997 ·Status: RECRUITING
-
Non-Invasive Diagnosis of Endometrial Cancer
NCT05737797 ·Status: RECRUITING ·Phase: NA
-
Cohort of Patients With Pelvic Gynecological Cancer: Constitution of a Collection of Biological Samples With Radioclinical Characterization
NCT03622983 ·Status: RECRUITING
-
Endometrial Cancer Testing With Vaginal and Endometrial Cell Samples
NCT01793545 ·Status: COMPLETED
-
Evaluation of Clinical and Molecular Biomarkers in Immunotherapy Treatment in Gynecologic Cancer
NCT06737640 ·Status: NOT_YET_RECRUITING
-
Role of Mitochondrial Bioenergetics in Resilience for Gynecologic Cancer
NCT07046936 ·Status: SUSPENDED
-
Identification and Characterization of Endometrial Cancer With Specific Tumor Markers in Serum and Endometrial Tissue
NCT03498924 ·Status: COMPLETED
-
Development and Management of Registry in Patients With Gynecologic Cancer in Korea
NCT05912972 ·Status: RECRUITING
-
The Study of Massively Parallel Sequencing in Early Detection for Gynecologic Malignant Tumor
NCT02166515 ·Status: UNKNOWN
-
Cervical Cancer Screening with NGS-HPV Technology Based on Menstrual Blood
NCT06082765 ·Status: RECRUITING
-
Endometrial Changes in Breast Cancer Women.
NCT05717634 ·Status: UNKNOWN
-
Prognostic and Diagnostic Added Value of Medical Imaging in Gynecological Cancer (PRODIGYN)
NCT05855941 ·Status: RECRUITING
-
Fertility-sparing in Early-stage Cervcial Cancer: The ETERNITY Project
NCT06351228 ·Status: NOT_YET_RECRUITING
-
Follow-up of Gynecological Cancer Patients, Their Needs and Expectations, A Cooperation Project
NCT01691144 ·Status: COMPLETED
-
Generation of Endometrial Carcinoma Organoids
NCT07258186 ·Status: RECRUITING
-
Identifying Biomarkers for Early Detection of Cancer in Patients With Cervical Dysplasia or Carcinoma in Situ of the Cervix
NCT00601601 ·Status: COMPLETED
-
Investigations of Reproductive Cancers in Women
NCT06527157 ·Status: RECRUITING
-
The Exploration of Personalized ctDNA Based MRD in the Clinical Significance of Cervical Cancer
NCT06283875 ·Status: NOT_YET_RECRUITING
-
Quality of Life in Survivors of Gynecologic Cancer
NCT00003795 ·Status: COMPLETED
-
Biospecimen Collection and Testing for the Prevalence of Anal Dysplasia and Anal Cancer in Patients With Cervical, Vaginal and Vulvar Dysplasia and Cancer
NCT02140021 ·Status: TERMINATED ·Phase: NA
-
Gene Expression Profiling of Cervical Cancer Progression in Biopsies and Tissue Samples
NCT00629577 ·Status: TERMINATED ·Phase: PHASE1
-
An Observational Study Based on Endometrial Cancer Risk Screening Model
NCT05634798 ·Status: UNKNOWN